![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 29, 25893-25903, July 19, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
§,
§,
§,
,
§
From the Expression of a 74-kDa nuclear
factor I (NFI) protein is triggered in early involution in the mouse
mammary gland, and its expression correlates with enhanced occupation
of a twin (NFI) binding element in the clusterin promoter,
a gene whose transcription is induced at this time (Furlong, E. E., Keon, N. K., Thornton, F. D., Rein, T., and Martin, F. (1996) J. Biol. Chem. 271, 29688-29697). We now
identify this 74-kDa NFI as an NFIC isoform based on its interaction in
Western analysis with two NFIC-specific antibodies. A transition from
the expression of a 49-kDa NFIC in lactation to the expression of the
74-kDa NFIC in early involution is demonstrated. We show that the
74-kDa NFIC binds specifically to concanavalin A (ConA) and that this
binding can be reversed by the specific ConA ligands, methyl
Conway Institute of Biomolecular and
Biomedical Research and § Department of Pharmacology,
University College Dublin, Belfield, Dublin 4, Ireland,
¶ Department of Clinical Research University of Bern,
Murtenstrasse 35, Bern, CH-3010 Switzerland, and
** Hannah Research Institute, Ayr, Scotland KA6 5HL, United
Kingdom
-D-mannopyranoside and methyl
-D-glucopyranoside. In addition, its apparent molecular
size was reduced to ~63 kDa by treatment with the peptide
N-glycosidase. The 49-kDa lactation-associated NFIC did not
bind ConA nor was it affected by peptide N-glycosidase. Tunicamycin, a specific inhibitor of N-glycosylation,
blocked formation of the 74-kDa NFI in involuting mouse mammary gland in vivo when delivered from implanted Elvax depot pellets.
Finally, the production of the ConA binding activity could be
reiterated in "mammospheres" formed from primary mouse mammary
epithelial cells associated with a laminin-rich extracellular matrix.
Synthesis of the 74-kDa NFIC was also inhibited in this setting by
tunicamycin. Thus, involution triggers the production of an NFIC
isoform that is post-translationally modified by
N-glycosylation. We further show, by using quantitative
competitive reverse transcriptase-PCR, that there is increased
expression of the major mouse mammary NFIC mRNA transcript,
mNFIC2, in early involution, suggesting that the
involution-associated change in NFIC expression also has a
transcriptional contribution.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number(s) AF358455-AF358460.
Present address: Novartis Pharma AG, Oncology Research,
WKL-125.2.42, 4002 Basel, Switzerland.

To whom correspondence should be addressed: Conway Institute of
Biomolecular and Biomedical Research, University College Dublin, Belfield, Dublin 4, Ireland. Tel.: 353-1-716-2808; Fax: 353-1-269-2016; E-mail: finian.martin@ucd.ie.
This article has been cited by other articles:
![]() |
S. Fauquenoy, W. Morelle, A. Hovasse, A. Bednarczyk, C. Slomianny, C. Schaeffer, A. Van Dorsselaer, and S. Tomavo Proteomics and Glycomics Analyses of N-Glycosylated Structures Involved in Toxoplasma gondii-Host Cell Interactions Mol. Cell. Proteomics, May 1, 2008; 7(5): 891 - 910. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ouellet, F. Vigneault, M. Lessard, S. Leclerc, R. Drouin, and S. L. Guerin Transcriptional regulation of the cyclin-dependent kinase inhibitor 1A (p21) gene by NFI in proliferating human cells Nucleic Acids Res., December 2, 2006; 34(22): 6472 - 6487. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Triantis, V. Moulin, M. W. G. Looman, F. C. Hartgers, R. A. J. Janssen, and G. J. Adema Molecular characterization of the murine homologue of the DC-derived protein DC-SCRIPT J. Leukoc. Biol., May 1, 2006; 79(5): 1083 - 1091. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Johansson, M. Kannius-Janson, A. Gritli-Linde, G. Bjursell, and J. Nilsson Nuclear Factor 1-C2 Is Regulated by Prolactin and Shows a Distinct Expression Pattern in the Mouse Mammary Epithelial Cells during Development Mol. Endocrinol., April 1, 2005; 19(4): 992 - 1003. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Wickenheisser, V. L. Nelson-DeGrave, P. G. Quinn, and J. M. McAllister Increased Cytochrome P450 17{alpha}-Hydroxylase Promoter Function in Theca Cells Isolated from Patients with Polycystic Ovary Syndrome Involves Nuclear Factor-1 Mol. Endocrinol., March 1, 2004; 18(3): 588 - 605. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Cotman, D. Jezek, K. F. Tacer, R. Frangez, and D. Rozman A Functional Cytochrome P450 Lanosterol 14{alpha}-Demethylase CYP51 Enzyme in the Acrosome: Transport through the Golgi and Synthesis of Meiosis-Activating Sterols Endocrinology, March 1, 2004; 145(3): 1419 - 1426. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. V. Minorsky Plant Physiology, September 1, 2003; 133(1): 14 - 15. [Full Text] [PDF] |
||||
![]() |
K. Luciakova, P. Barath, D. Poliakova, A. Persson, and B. D. Nelson Repression of the Human Adenine Nucleotide Translocase-2 Gene in Growth-arrested Human Diploid Cells: THE ROLE OF NUCLEAR FACTOR-1 J. Biol. Chem., August 15, 2003; 278(33): 30624 - 30633. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |